SCHEMBL3749548

SCHEMBL3749548

CC(C)(C)OC(=O)NC(=O)Oc1nccs1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
PKM P14618 2/20 0.37
HTT P42858 1/20 0.37
HIF1A Q16665 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ALDH1A1 P00352 2/20 0.36
ATR Q13535 1/20 0.35
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
CTSL P07711 1/20 0.33
CTSS P25774 1/20 0.33
CTSK P43235 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19974181 0.80 PKM (0.39) L3MBTL1MEN1KMT2APKMHTT
SCHEMBL25425081 0.79 KDM4E (0.44) METAP1L3MBTL1HTTNPSR1ALDH1A1
SCHEMBL28772041 0.77 L3MBTL1 (0.42) L3MBTL1MEN1KMT2APKMHTT
SCHEMBL28662188 0.77 METAP1 (0.50) METAP1L3MBTL1KMT2AALDH1A1
SCHEMBL27979962 0.74 L3MBTL1 (0.39) L3MBTL1MEN1KMT2APKMHTT
SCHEMBL14720 0.73 METAP1 (0.66) METAP1L3MBTL1MEN1KMT2APKM
SCHEMBL15764379 0.72 METAP1 (0.46) METAP1SMN1; SMN2LMNA
SCHEMBL3559527 0.71
SCHEMBL27567716 0.71 METAP1 (0.53) METAP1L3MBTL1MEN1KMT2APKM
SCHEMBL25229225 0.71 METAP1 (0.40) METAP1L3MBTL1MEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4583870-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER Mito Biopharma, LLC (US) 2025-07-16 EP disclosed
WO-2024054766-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER MITO BIOPHARMA, LLC (US) 2024-03-14 WO disclosed
EP-2176256-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES AstraZeneca AB (SE) 2010-04-21 EP disclosed
WO-2009007751-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed